SCHEMBL3466653

SCHEMBL3466653

N#Cc1ccc2c(c1)CN(CC(=O)O)CC2

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 14/20 0.60
DRD3 P35462 12/20 0.60
DRD4 P21917 2/20 0.55
OPRM1 P35372 2/20 0.55
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
AKR1C3 P42330 2/20 0.49
HTR1D P28221 3/20 0.48
HTR1B P28222 3/20 0.48
S1PR1 P21453 1/20 0.48
HTR1A P08908 1/20 0.47
HTR2A P28223 1/20 0.47
SLC6A4 P31645 1/20 0.47
HTR7 P34969 1/20 0.47
HRH1 P35367 1/20 0.47
HTR2B P41595 1/20 0.47
PRMT5 O14744 1/20 0.44
WDR77 Q9BQA1 1/20 0.44
CYP2D6 P10635 2/20 0.44
ITGB3 P05106 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL774065 0.86 DRD2 (0.64) DRD2DRD3DRD4OPRM1KDM4E
SCHEMBL81130 0.80 DRD2 (0.74) DRD2DRD3DRD4OPRM1KDM4E
SCHEMBL12663322 0.80 DRD2 (0.66) DRD2DRD3DRD4OPRM1KDM4E
SCHEMBL28369820 0.78 AKR1C3 (0.52) DRD2DRD3DRD4OPRM1AKR1C3
SCHEMBL13345546 0.78 MEN1 (0.52) DRD2DRD3KDM4EALDH1A1AKR1C3
SCHEMBL4429103 0.78 ITGB3 (0.70) S1PR1ITGB3ITGA2B
SCHEMBL19035635 0.78 DRD3 (0.60) DRD2DRD3DRD4OPRM1KDM4E
SCHEMBL3478431 0.76 ALDH1A1 (0.59) DRD2DRD3KDM4EALDH1A1HTR1A
SCHEMBL12277698 0.75 HTR5A (0.48) DRD2DRD3DRD4OPRM1KDM4E
SCHEMBL15756199 0.75 OPRD1 (0.47) S1PR1ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376484-B1 OXADIAZOLE FUSED HETEROCYCLIC DERIVATIVES USEFUL FOR THE TREATMENT OF MULTIPLE SCLEROSIS MERCK SERONO SA (CH) 2015-04-22 EP disclosed
US-8741923-B2 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis MERCK SERONO SA (CH) 2014-06-03 US disclosed
WO-2010069949-A1 OXADIAZOLE FUSED HETEROCYCLIC DERIVATIVES USEFUL FOR THE TREATMENT OF MULTIPLE SCLEROSIS MERCK SERONO S.A. (CH) 2010-06-24 WO disclosed